Top analysts suggest these 3 dividend stocks for stable income
Corporate earnings along with geopolitical concerns have swayed investor sentiment in recent trading sessions. But investors seeking consistent…
At 95, Buffett is still sharpest dealmaker with $10 billion OxyChem deal
Warren Buffett’s shrewd dealmaking instincts remain intact even as the 95-year-old legendary investor inches close to the end…
What’s likely to move the market in the next trading session
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…